Investor Relations

Webcast ImageOppenheimer 28th Annual Healthcare Conference (Live)
03/21/18 at 8:35 a.m. ET
Oppenheimer 28th Annual Healthcare Conference
Wednesday, March 21, 2018 8:35 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Zynerba (NASDAQ: ZYNE) is dedicated to improving the lives of people with rare and near rare neuropsychiatric disorders where there is a high unmet medical need by pioneering the development and commercialization of next-generation pharmaceutically-produced cannabinoid therapeutics formulated for transdermal delivery. Cannabinoids interact with specific receptors throughout the body to produce pharmacologic effects, primarily in the CNS and immune systems.

More >>
Stock Quote
ZYNE (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Down 0.75 (0.00%)
Data as of 03/16/18 4:00 p.m. ET